SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech for less than a buck.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RWReeves who wrote (310)1/6/2000 1:59:00 PM
From: BulbaMan  Read Replies (1) of 743
 
XENO is a strange little (or more accurately, minuscule) company. But a quick perusal of their most recent 10Q seems to indicate it's worth more than its $2 million market cap. My rough guess is their accumulated deficit of $15.9 million should be worth about $1 a share to an acquirer as a tax loss. XENO's intellectual property (mostly gene expression patents) is more difficult to evaluate. But their intellectual property could be worth a few million as it produced $443,000 in net licensing revenues for the Sep. 99 quarter. Has anyone else checked out XEON? Info on their patents would be especially appreciated.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News